BioLineRx Ltd.
TREATMENT OF METASTATIC PANCREATIC ADENOCARCINOMA
Last updated:
Abstract:
A method of treating metastatic pancreatic adenocarcinoma in a subject in need thereof is provided. The method comprising administering to the subject a therapeutically effective amount of each of a peptide set forth in SEQ ID NO: 1, an anti PD-1 and a chemotherapy, thereby treating the metastatic pancreatic adenocarcinoma.
Status:
Application
Type:
Utility
Filling date:
17 Oct 2019
Issue date:
13 Jan 2022